Already have an account? Sign in instead.
You stay signed in for 30 days on this browser.
Continue with Google Continue with MicrosoftNo account yet? Create a free one.
We sent a six-digit code.
It expires in ten minutes, works once, and only in this browser. Five wrong tries void it. Send another code.
Your account is live and the Cloudflare checks are off for this browser.
Definitions and special rules
Courts have cited this section in 4 opinions since 2013, 1 of them in the last five years.
The term “vaccine” means any substance designed to be administered to a human being for the prevention of 1 or more diseases.
The term “United States” has the meaning given such term by section 4612(a)(4).
The term “importer” means the person entering the vaccine for consumption, use, or warehousing.
Paragraph (1) shall apply to any returned or destroyed vaccine only with respect to claims filed within 6 months after the date the vaccine is returned or destroyed.
No tax shall be imposed by section 4131 on the sale of any vaccine if tax was imposed by section 4131 on any prior sale of such vaccine and such tax is not abated, credited, or refunded.
Any manufacturer, producer, or importer of a vaccine which uses such vaccine before it is sold shall be liable for the tax imposed by section 4131 in the same manner as if such vaccine were sold by such manufacturer, producer, or importer.
Section 4221(a)(2) shall not apply to any vaccine shipped to a possession of the United States.
In the case of a fraction of a dose, the tax imposed by section 4131 shall be the same fraction of the amount of such tax imposed by a whole dose.
The provisions of subsections (a)(3) and (b)(3) of section 7652 shall not apply to any tax imposed by section 4131.
2013—Subsec. (a)(1)(N). Pub. L. 113–15 inserted “or any other vaccine against seasonal influenza” before period at end.
2006—Subsec. (a)(1)(O), (P). Pub. L. 109–432 added subpars. (O) and (P).
2004—Subsec. (a)(1)(I) to (M). Pub. L. 108–357, § 889(a), added subpar. (I) and redesignated former subpars. (I) to (L) as (J) to (M), respectively.
Subsec. (a)(1)(N). Pub. L. 108–357, § 890(a), added subpar. (N).
1999—Subsec. (a)(1)(K). Pub. L. 106–170, § 523(b)(1), repealed Pub. L. 105–277, § 1503(a). See 1998 Amendment note below.
Subsec. (a)(1)(L). Pub. L. 106–170, § 523(a)(1), added subpar. (L).
1998—Subsec. (a)(1)(K). Pub. L. 105–277, § 3002(a), added a subpar. (K) identical to that added by Pub. L. 105–277, § 1503(a). See below.
Pub. L. 105–277, § 1503(a), which directed amendment of section 4132(1) by adding a new subpar. (K) at the end, was repealed by Pub. L. 106–170, § 523(b)(1).
1997—Subsec. (a)(1). Pub. L. 105–34, § 904(b), amended heading and text of par. (1) generally. Prior to amendment, text read as follows: “The term ‘taxable vaccine’ means any vaccine—
“(A) which is listed in the table contained in section 4131(b)(1), and
“(B) which is manufactured or produced in the United States or entered into the United States for consumption, use, or warehousing.”
Subsec. (a)(2) to (8). Pub. L. 105–34, § 904(c), redesignated pars. (6) to (8) as (2) to (4), respectively, and struck out former pars. (2) to (5) which read as follows:
“(2) DPT
“(3) DT
“(4) MMR
“(5)
1988—Subsec. (c). Pub. L. 100–647 added pars. (1) and (2) and redesignated former pars. (1) and (2) as (3) and (4), respectively.
Pub. L. 113–15, § 1(b),
Pub. L. 109–432, div. A, title IV, § 408(c),
Pub. L. 108–357, title VIII, § 889(b),
Pub. L. 108–357, title VIII, § 890(b),
Pub. L. 106–170, title V, § 523(a)(2),
Pub. L. 106–170, title V, § 523(b)(3),
Pub. L. 105–277, div. C, title XV, § 1503(b), div. I, title III, § 3002(b),
Amendment by Pub. L. 105–34 effective on the day after
Pub. L. 100–647, title II, § 2006(c),
Pub. L. 105–34, title IX, § 904(e),
The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.
One bar per year. Tallest: 1 case in 2013. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.
Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.
Edition shown: U.S. Code current through Pub. L. 119-102 (OLRC release point). Syfert holds no earlier or later version of this section.